+44 20 8123 2220 [email protected] Johnson & Johnson (JNJ) - Pharmaceuticals & Healthcare - Deals and Alliances Profile https://marketpublishers.com/r/JCB7887443BEN.html Date: October 2018 Pages: 632 Price: US$ 250.00 (Single User License) ID: JCB7887443BEN Abstracts Summary Johnson & Johnson (J&J) researches and develops, and manufactures and sells a range of pharmaceutical products, medical devices and consumer products. The company provides pharmaceuticals for immune diseases, cancer, neurological disorders, infectious, cardiovascular and metabolic diseases; consumer products in baby care, oral care, beauty, over-the-counter (OTC) pharmaceutical, women’s health and wound care categories; and medical devices for use in the cardiovascular, orthopedic, surgery, diabetes care and vision care fields. J&J distributes pharmaceutical and medical products to retailers, wholesalers, health care professionals and hospitals; and offers consumer products through retail outlets and distributors. The company offers its products in the US; Europe; Asia-Pacific and Africa; and Western Hemisphere (excluding the US). J&J is headquartered in New Brunswick, New Jersey, the US. Johnson & Johnson (JNJ) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions. GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research. Scope Johnson & Johnson (JNJ) - Pharmaceuticals & Healthcare - Deals and Alliances Profile +44 20 8123 2220 [email protected] Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios. Business Description - A brief description of the company's operations. Key Employees - A list of the key executives of the company. Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. Key Competitors - A list of the key competitors of the company. Key Recent Developments - A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand Johnson & Johnson (JNJ) - Pharmaceuticals & Healthcare - Deals and Alliances Profile +44 20 8123 2220 [email protected] the company's expansion/divestiture and fund requirements The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion/divestiture strategy The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay up-to-date on the major developments affecting the company Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Johnson & Johnson (JNJ) - Pharmaceuticals & Healthcare - Deals and Alliances Profile +44 20 8123 2220 [email protected] Note: Some sections may be missing if data is unavailable for the company. Johnson & Johnson (JNJ) - Pharmaceuticals & Healthcare - Deals and Alliances Profile +44 20 8123 2220 [email protected] Contents Johnson & Johnson, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 Johnson & Johnson, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 Johnson & Johnson, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 Johnson & Johnson, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 Johnson & Johnson, Medical Devices Deals, 2012 to YTD 2018 Johnson & Johnson, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 Johnson & Johnson, Pharmaceuticals & Healthcare, Deal Details Asset Purchase Janssen Pharma Acquires CERC-501 from Cerecor Cilag Acquires Rights to Rhinocort Aqua Outside the US from Astrazeneca Janssen Pharma Acquires Royalty Rights To Incivo From Vertex Pharma For US$152 Million Janssen Pharma Acquires Investigational NS5A Inhibitor From Medivir Venture Financing Twentyeight-Seven Therapeutics Raises USD65 Million in Series A Venture Financing PhaseBio Pharma Raises USD34 Million in Series D Venture Financing ApoGen Biotech Raises Additional USD4 Million in Series A Financing Magnolia Neurosciences Raises USD31 Million in Series A Venture Financing Evolve BioSystems Raises USD40 Million in Series C Financing Syndesi Therapeutics Raises USD21 Million in Series A Financing On Target Labs Raises USD40 Million in Series B Financing BeneVir Biopharm Raises USD2 Million in Venture Financing Fusion Pharma Raises Additional USD17 Million in Series A Financing XW Labs Raises USD17.5 Million in Series B Financing Rodeo Therapeutics Raises USD5.9 Million in Series A Financing E-scape Bio Raises Additional USD8 Million in Series A Financing DayTwo Secures USD12 Million in Series A Funding DayTwo Raises USD12 Million in Series A Financing Aragon Pharmaceuticals Raises USD22 Million in Series B Round of Financing Biomx Raises USD24 Million in Series A Venture Financing Pulmocide Raises USD30.4 Million in Series B Financing Fusion Pharma Raises USD19 Million in Series A Financing SuperX Raises USD11 Million in Series A Financing Caelus Health Raises USD2.7 Million in Series A Financing Johnson & Johnson (JNJ) - Pharmaceuticals & Healthcare - Deals and Alliances Profile +44 20 8123 2220 [email protected] ApoGen Biotech Raises USD7 Million in Series A Financing ReVision Optics Raises USD32 Million in Venture Financing Blackthorn Therapeutics Raises USD40 Million in Series A Financing BeneVir Biopharm Raises USD3 Million in Venture Financing V-Wave Raises USD28 Million in Venture Financing Lodo Therapeutics Raises USD17 Million in Series A Financing Aelix Therapeutics Raises USD12.7 Million in Series A Financing Petra Pharma Raises USD48 Million in Series A Financing Protekt Therapeutics Raises More Than USD2 Million in Financing Navitor Pharma Raises USD33 Million in Series B Financing First Aid Shot Therapy Raises USD24 Million in Series C Financing PrEP Biopharm Raises USD32.4 Million in Series A Financing Round Asceneuron Raises USD30.6 Million in Series A Financing Merus Raises USD46.4 Million in First Tranche of Series C Financing E-scape Bio Raises USD55 Million in Series A Financing Alligator Bioscience to Raise Funds through Venture Financing Protagonist Therapeutics Raises USD40 Million in Series C Financing PhaseBio Pharma Raises USD40 Million in Series C Venture Financing Protagonist Therapeutics Raises Additional Funds through Second Tranche of Series B Venture Financing BeneVir Biopharm Raises Funds through Series A Financing Tetra Discovery Raises Funds through Venture Financing XW Labs Raises USD5.5 Million in Series A Financing Inviata Raises USD6.5 Million in Venture Financing ViaCyte Raises Additional USD5.4 Million in Series C-1 Venture Financing Ascelegen Therapeutics Raises Funds through Venture Financing Padlock Therapeutics Raises Funds through Series A Financing Navitor Pharma Raises USD24 Million in Series A Financing Aduro BioTech Raises USD55 Million in Series C Financing Rodin Therapeutics Raises USD13 Million in Series A Venture Financing Assembly Pharma Raises Funds Through Seed Financing Alios BioPharma Raises US$41 Million In Series B Venture Financing Covagen Raises US$50.3